The DOI matches its Crossref record.
Angiotensin-(1–7) Is a Modulator of the Human Renin-Angiotensin System
Open accessAbstract
Abstract—The renin-angiotensin system is important for cardiovascular homeostasis. Currently, therapies for different cardiovascular diseases are based on inhibition of angiotensin-converting enzyme (ACE) or angiotensin II receptor blockade. Inhibition of ACE blocks metabolism of angiotensin-(1–7) to angiotensin-(1–5) and can lead to elevation of angiotensin-(1–7) levels in plasma and tissue. In animal models, angiotensin-(1–7) itself causes or enhances vasodilation and inhibits vascular contractions to angiotensin II. The function of angiotensin-(1–5) is unknown. We investigated whether angiotensin-(1–7) and angiotensin-(1–5) inhibit ACE or antagonize angiotensin-induced vasoconstrictions in humans. ACE activity in plasma and atrial tissue was inhibited by angiotensin-(1–7) up to 100%, with an IC 50 of 3.0 and 4.0 μmol/L, respectively. In human internal mammary arteries, contractions induced by angiotensin I and II and the non–ACE-specific substrate [Pro 11,D-Ala 12]-angiotensin I were antagonized by angiotensin-(1–7) (10−5 mol/L) in a noncompetitive way, with a 60% inhibition of the maximal response to angiotensin II. Contractions to ACE-specific substrate [Pro 10]-angiotensin I were also inhibited, an effect only partly accounted for by antagonism of angiotensin II. Angiotensin-(1–5) inhibited plasma ACE activity with a potency equal to that of angiotensin I but had no effect on arterial contractions. In conclusion, angiotensin-(1–7) blocks angiotensin II–induced vasoconstriction and inhibits ACE in human cardiovascular tissues. Angiotensin-(1–5) only inhibits ACE. These results show that angiotensin-(1–7) may be an important modulator of the human renin-angiotensin system.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Angiotensin-(1–7) is an endogenous ligand for the G protein-coupled receptor Mas
Santos, R. A. S., e Silva, A. C. S., Maric, C., Silva, D. M. R., Machado, R. P., de Buhr, I., Heringer-Walther, S., Pinheiro, S. V. B., Lopes, M. T., Bader, M., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1432869100 · Cited by 1,801
The ACE2/angiotensin-(1-7)/MAS Axis of the renin-angiotensin system: focus on angiotensin-(1-7)
Santos, R. A. S., Sampaio, W. O., Alzamora, A. C., Motta-Santos, D., Alenina, N., Bader, M., & Campagnole-Santos, M. J. (2018) · Physiological Reviews · doi:10.1152/physrev.00023.2016 · Cited by 1,144
COVID-19 and diabetes mellitus: from pathophysiology to clinical management
Lim, S., Bae, J. H., Kwon, H.-S., & Nauck, M. A. (2021) · Nature Reviews Endocrinology · doi:10.1038/s41574-020-00435-4 · Cited by 1,006
Santos, R. A. S., Ferreira, A. J., Verano-Braga, T., & Bader, M. (2013) · Journal of Endocrinology · doi:10.1530/joe-12-0341 · Cited by 523
Potential influence of COVID-19/ACE2 on the female reproductive system
Jing, Y., Run-Qian, L., Hao-Ran, W., Hao-Ran, C., Ya-Bin, L., Yang, G., & Fei, C. (2020) · Molecular Human Reproduction · doi:10.1093/molehr/gaaa030 · Cited by 409
The angiotensin–converting enzyme gene family: genomics and pharmacology
Turner, A. J., & Hooper, N. M. (2002) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01994-5 · Cited by 406
Santos, R. A. S., Campagnole-Santos, M. J., & Andrade, S. P. (2000) · Regulatory Peptides · doi:10.1016/s0167-0115(00)00138-5 · Cited by 380
Chronic liver injury in rats and humans upregulates the novel enzyme angiotensin converting enzyme 2
Paizis, G., Tikellis, C., Cooper, M. E., Schembri, J. M., Lew, R. A., Smith, A. I., Shaw, T., Warner, F. J., Zuilli, A., Burrell, L. M., et al. (2005) · Gut · doi:10.1136/gut.2004.062398 · Cited by 334
Angiotensin-(1–7) Attenuates the Development of Heart Failure After Myocardial Infarction in Rats
Loot, A. E., Roks, A. J. M., Henning, R. H., Tio, R. A., Suurmeijer, A. J. H., Boomsma, F., & van Gilst, W. H. (2002) · Circulation · doi:10.1161/01.cir.0000013847.07035.b9 · Cited by 321
Self-citationIwai, M., & Horiuchi, M. (2009) · Hypertension Research · doi:10.1038/hr.2009.74 · Cited by 296
Angiotensin-(1-7) Counterregulates Angiotensin II Signaling in Human Endothelial Cells
Sampaio, W. O., Henrique de Castro, C., Santos, R. A. S., Schiffrin, E. L., & Touyz, R. M. (2007) · Hypertension · doi:10.1161/hypertensionaha.106.084848 · Cited by 283
ACE2 of the heart: From angiotensin I to angiotensin (1–7)
KEIDAR, S., KAPLAN, M., & GAMLIELLAZAROVICH, A. (2007) · Cardiovascular Research · doi:10.1016/j.cardiores.2006.09.006 · Cited by 278
Santos, R. A. (2014) · Hypertension · doi:10.1161/hypertensionaha.113.01274 · Cited by 259
Stewart, J. M., Ocon, A. J., Clarke, D., Taneja, I., & Medow, M. S. (2009) · Hypertension · doi:10.1161/hypertensionaha.108.127357 · Cited by 59
Loloi, J., Miller, A. J., Bingaman, S. S., Silberman, Y., & Arnold, A. C. (2018) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00281.2018 · Cited by 30
Metadata
- Authors
- Roks, A. J. M., van Geel, P. P., Pinto, Y. M., Buikema, H., Henning, R. H., de Zeeuw, D., & van Gilst, W. H.
- Venue
- Hypertension
- Published
- 1999-08
- Volume
- 34
- Issue
- 2
- Pages
- 296-301
- ISSN
- 0194-911X (ISSN-L)
- 1524-4563
- OpenAlex
- W1991854388
- Cited by
- 190
- References
- 0
- FWCI
- 5.43
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.